DELCATH SYSTEMS, INC.

Develops targeted chemotherapy delivery systems for treating primary and metastatic liver cancers.

DCTH | NDAQ

Overview

Corporate Details

ISIN(s):: N/A
LEI:
Country:: United States of America
Address:: 566 QUEENSBURY AVENUE, 12804 QUEENSBURY
Website:: https://delcath.com/
Sector:: Manufacturing
Industry:: Manufacture of medical and dental instruments and supplies

Description

Delcath Systems, Inc. is a commercial-stage, interventional oncology company focused on treating primary and metastatic liver cancers. The company develops and commercializes specialty pharmaceutical and medical device products based on its proprietary percutaneous hepatic perfusion (PHP) technology. This minimally-invasive procedure is designed to deliver high-dose chemotherapy directly to the liver while controlling systemic side effects. Its flagship products are the HEPZATO KIT™, recently FDA-approved in the U.S. for treating metastatic uveal melanoma, and the CHEMOSAT® Hepatic Delivery System, a medical device available in Europe. Delcath aims to provide targeted, minimally-invasive treatment options for patients with liver-dominant cancers.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all DELCATH SYSTEMS, INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for DELCATH SYSTEMS, INC.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for DELCATH SYSTEMS, INC. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
AtriCure, Inc. Develops surgical devices for Afib, LAA management, and non-opioid pain relief.	United States of America	ATRC
AuBEX CORPORATION High-precision manufacturer of nibs for stationery, cosmetics, and medical infusion technology.	Japan	3583
Audientes A/S Develops smart, self-fitting, and affordable hearing aids for adults with hearing loss.	Denmark	AUDNTS
AVANOS MEDICAL, INC. Medical devices for non-opioid pain management and chronic care enteral feeding solutions.	United States of America	AVNS
AVITA Medical, Inc. Regenerative solutions for burns and wounds using a patient's own Spray-On Skin™ Cells.	United States of America	RCEL
Axogen, Inc. Develops surgical solutions, including nerve allografts, for peripheral nerve repair and regeneration.	United States of America	AXGN
Bactiguard Holding Licenses a patented coating to MedTech partners to prevent medical device infections.	Sweden	BACTI
Bausch & Lomb Corp A global eye health company offering contact lenses, pharmaceuticals, and surgical devices for all.	United States of America	BLCO
BAXTER INTERNATIONAL INC Provides life-sustaining products for IV, surgical, and renal care in hospitals and homes.	United States of America	BAX
BBS-Bioactive Bone Substitutes Oyj Developed a bioactive bone graft substitute for orthopedic surgery before filing for bankruptcy.	Finland	BONE